Bosnalijek d.d.

home

dobrodošli

14.1.2010 Bosnalijek increases export share in total income from sales
According to preliminary data, Bosnalijek d.d. (Bosnalijek) realized a net profit of 9 million KM in 2009. A carefully implemented business strategy and internal savings enabled the Company to increase its net profit by 11% as compared to 2008, despite the financial crisis whose effects have shaken export markets, especially those in Russia and Eastern Europe.
Last year Bosnalijek launched 9 new products on the markets.

12.12.2009 Bosnalijek supported the celebration of the 50th anniversary of the Physical Medicine and Rehabilitation Clinic of the University Clinical Center Tuzla

2.12.2009 Higher Bosnalijek exposure to international investors




		Bronchobos stops cough and makes easier breathing

		How to eliminate symptoms of cold and flu?

		Top quality Bostrombin is recommended

		Royal Jelly - natural stimulant of the organism

		Golderm - Unique product for rapid healing of the skin

		Golderm gel - Rapidly renews damaged skin

SASE stock exchange

Date:08.02.2010 › Price:16,51 KM › Change:0,67%á › Best buy:16,22 KM › Best sell:16,52 KM › Volume:845 › Value:13.935,49 KM › Number of transactions:8 › Shares issued:7.829.978 › Market cap:129.272.936,78 KM


		Annual reports

		Audited financial reports

Bosnalijek product overview